Bochum

Germany

229 total trials 95 recruiting

Filter these 229 trials by phase, condition, sponsor and more.

Open in Search →

Study to investigate the efficacy and safety of allo-APZ2-CVU on wound healing of therapy-resistant chronic venous ulcer (CVU) Ended

2023-510162-27-00 4 2021-08-18 Chronic venous ulcers (CVU)
An extension study to learn if Bimekizumab is safe and works as a long-term therapy in adults with moderate to severe hidradenitis suppurati … Ended

2024-511035-10-00 5 2021-06-23 Hidradenitis Suppurativa
A clinical trial which runs in multiple countries and aims to evaluate the long-term safety and tolerability of the investigational product … Ended

2024-512123-37-00 5 2021-05-27 Parkinson's disease
A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS2) Ended

2023-506724-85-00 5 2020-11-19 Migraine
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS1) Ended

2023-506253-38-00 5 2020-11-09 Migraine
Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor tolebrutinib (SAR442168) (PERSEUS) Ended

2024-514495-41-00 5 2020-11-04 Primary Progressive Multiple Sclerosis
RACE-trial: Neoadjuvant Radiochemotherapy versus Chemotherapy for Patients with Locally Advanced, Potentially Resectable Adenocarcinoma of t … Ended

2024-516271-32-00 5 2020-06-03 Adenocarcinoma of the gastroesophageal junction (AEG type I-III)
An Open-Label, Multi-Center Extension Study to Characterize the Long-Term Safety and Efficacy of BMS-986165 in Subjects with Moderate-to-Sev … Ended

2022-502361-15-00 5 2019-12-12 Moderate-to-Severe Plaque Psoriasis
CIRCULATE Ended

2023-506715-18-00 5 2019-12-04 colon cancer stage II, rectal cancer stage II
A study to assess different investigational drugs for the treatment if hidradenitis suppurativa Ended

2023-509296-16-00 4 2019-06-17 Moderate to severe hidradenitis suppurativa
A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy with Atezolizumab or Placebo in Patients with Triple-Negati … Ended

2023-508472-11-00 5 2018-06-13 Patients with early breast cancer
HD21 Ended

2024-518022-33-00 5 2016-07-15 Advanced Stage of Hodgkin Lymphoma
Double-blind, Randomized, Placebo-controlled Study Evaluating Efficacy and Safety of IgPro20 in post-COVID-19 POTS Ended

2023-508744-22-00 5 Post-COVID-19 Postural Orthostatic Tachycardia Syndrome

Showing 217–229 of 229 trials